Gemma Salvadó
11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Biomarker-based staging of Alzheimer disease : rationale and clinical applications
- Contribution to journal › Scientific review
-
Mark
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
- Contribution to journal › Article
-
Mark
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
- Contribution to journal › Article
-
Mark
Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer’s disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
- Contribution to journal › Article
-
Mark
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
- Contribution to journal › Article
- 2023
-
Mark
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
- Contribution to journal › Article
-
Mark
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population : The ABIDE project
- Contribution to journal › Article
-
Mark
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
APOE -ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
- Contribution to journal › Article
